10-K/A: Edgewell Personal Care Amends Annual Report to Include Omitted Exhibits and Certifications

Sentiment:

Annual Report Amendment


Edgewell Personal Care Company filed an amendment to its annual report to include previously omitted exhibits and new certifications from its CEO and CFO.

Summary

  • Edgewell Personal Care Company has filed an amendment to its annual report on Form 10-K for the fiscal year ended September 30, 2024.
  • The amendment, filed on November 21, 2024, includes exhibits 10.44, 19.1, 97.1 and 104, which were inadvertently omitted from the original filing on November 14, 2024.
  • The company also filed new certifications from the Chief Executive Officer and Chief Financial Officer as exhibits 31.3 and 31.4.
  • The amendment does not update any other disclosures from the original report and should be read in conjunction with the original filing and subsequent SEC filings.
  • The company's common stock is traded on the New York Stock Exchange under the symbol EPC.
  • As of October 31, 2024, there were 48,721,170 shares of common stock outstanding.

Sentiment

Score: 6

Explanation: The sentiment is neutral as the document is a routine amendment to correct omissions. There are no indications of positive or negative financial performance, but the need for an amendment does introduce a slight negative tone.

Positives

  • The company is taking steps to correct omissions in its original filing.
  • The inclusion of the omitted exhibits provides a more complete picture of the company's financial and operational status.
  • The new certifications from the CEO and CFO reinforce the accuracy of the financial statements.

Negatives

  • The need for an amendment suggests a potential oversight in the initial filing process.
  • The omission of exhibits could raise concerns about the company's internal controls.

Risks

  • The company's internal controls may need review to prevent future omissions.
  • The amendment could lead to increased scrutiny from regulators and investors.
  • Any further errors or omissions could negatively impact investor confidence.

Future Outlook

The document does not contain any forward-looking statements or guidance.

Management Comments

  • Rod R. Little, President and Chief Executive Officer, certified the accuracy of the report.
  • Daniel J. Sullivan, Chief Financial Officer, certified the accuracy of the report.

Industry Context

This is a standard regulatory filing for a publicly traded company and does not indicate any specific industry trends or competitive pressures.

Comparison to Industry Standards

  • The filing of an amended 10-K is not uncommon, especially when exhibits are inadvertently omitted.
  • Companies like Procter & Gamble (PG) and Unilever (UL) also file similar reports and amendments as part of their regulatory compliance.
  • The inclusion of CEO and CFO certifications is a standard practice for public companies to ensure accountability and accuracy in financial reporting.

Management Changes

RolePrevious PersonNew PersonEffective DateReason
Chief Financial OfficerNADaniel J. SullivanOctober 31, 2024Employment Offer Letter

Corporate Governance

Change TypeDescriptionEffective DateImpact Assessment
Compensation Recovery PolicyThe company has a compensation recovery policy in place to recoup erroneously awarded compensation to executive officers.October 2, 2023This policy is intended to comply with Section 10D of the Exchange Act and Section 303A.14 of the NYSE Listed Company Manual.
Insider Trading PolicyThe company has an insider trading policy to ensure that directors, officers, and employees do not violate insider trading laws.July 2023This policy prohibits trading on material non-public information and includes restrictions on speculative trading and hedging transactions.

Stakeholder Impact

  • Shareholders will receive a more complete and accurate annual report.
  • Employees are subject to the company's insider trading policy.
  • Executive officers are subject to the company's compensation recovery policy.

Next Steps

  • The company will file its definitive proxy statement within 120 days after September 30, 2024.
  • The company will continue to comply with SEC reporting requirements.

Key Dates

DateDescription
September 30, 2024End of the fiscal year for which the annual report was filed.
October 31, 2024Date of the number of shares of common stock outstanding.
November 14, 2024Date of the original filing of the Annual Report on Form 10-K.
November 21, 2024Date of the filing of the Amendment No. 1 to the Annual Report on Form 10-K/A.

Keywords

amendment, annual report, exhibits, certifications, financial statements, SEC filing, Edgewell Personal Care, corporate governance

Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.